Top

Published in:

01-02-2006 | Journal club critique

Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes

Authors: Lillian L. Emlet, David Crippen

Published in: Critical Care | Issue 1/2006

Excerpt

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785 [1]. …

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352: 777-785. 10.1056/NEJMoa042991CrossRefPubMed

Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344: 1450-1460. 10.1056/NEJM200105103441907CrossRefPubMed

Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G: Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993, 24: 987-993.CrossRefPubMed

Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Buller HR, Levi M: Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003, 361: 201-205. 10.1016/S0140-6736(03)12268-4CrossRefPubMed

Novo Nordisk: Recombinant Factor VIIa in Acute Intracerebral Haemorrhage. ClinicalTrials gov [Internet] Bethesda (MD): National Library of Medicine; 2000-[cited 2005 Dec 5] NLM Identifier:NCT00127283. [http://www.clinicaltrials.gov/ct/show/NCT00127283]

Title: Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes
Authors: Lillian L. Emlet
David Crippen
Publication date: 01-02-2006
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2006
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc3978

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2006

Recent evolution of renal replacement therapy in the critically ill patient

The key advance in the treatment of sepsis in the last 10 years ... doing less

Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome

Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients

Alvarez A (Editor-in-Chief), Brodsky J, Alpert M, Cowan G (Associated Editors): Morbid Obesity: Peri-operative Management. New York: Cambridge University Press

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation